Ossining, New York
United States
34
2014-12-25
The entities that hold a legal rights for patent applications filed by inventor Olson William C.:
William C. Olson from Ossining, US has applied for patents for these inventions. The list has both pending applications and granted patents:
METHODS FOR INHIBITING HIV-1 REPLICATION INVOLVING THE ADMINISTRATION OF AN ANTI-CCR5 RECEPTOR MONOCLONAL ANTIBODY AND SMALL MOLECULE CCR5 RECEPTOR ANTAGONIST
#2 | 2013-08-15METHOD FOR PREVENTING HIV-1 INFECTION OF CD4+ CELLS
#3 | 2011-08-18Methods for inhibiting HIV-1 replication involving the administration of an anti-CCR5 receptor monoclonal antibody and small molecule CCR5 receptor antagonist
#4 | 2010-12-28Methods of inhibiting human immunodeficiency virus type 1 (HIV-1) infection through the administration of CCR5 chemokine receptor antagonists
#5 | 2010-12-14PSMA antibodies and protein multimers
#6 | 2009-01-20Nucleic acids encoding mutant disulfide bond-stabilized human immunodeficiency virus type 1 (HIV-1) gp140 envelope glycoproteins
#7 | 2008-11-20Compositions of PSMA antibodies
#8 | 2008-11-06Hiv-1 Neutralizing Antibodies Elicited By Trimeric Hiv-1 Envelope Glycoprotein Complex
#9 | 2008-10-02Methods for reducing viral load in HIV-1-infected patients
#10 | 2008-08-07Method for preventing HIV-1 infection of CD4 cells
#11 | 2008-06-12CCR5 chemokine receptor-specific monoclonal antibodies capable of inhibiting HIV-1 cell fusion
#12 | 2008-05-08Anti-CCR5 antibody
#13 | 2008-01-17Nucleic acids encoding polypeptides of anti-CCR5 antibodies
#14 | 2007-11-29Compositions comprising anti-CCR5 antibody
#15 | 2007-10-04Anti-CCR5 antibodies
#16 | 2007-07-12PSMA antibody-drug conjugates
#17 | 2007-02-08Anti-CCR5 antibody
#18 | 2007-02-01Methods for reducing viral load in HIV-1-infected patients
#19 | 2007-01-25Methods of inhibiting human immunodeficiency virus infection through the administration of synergistic combinations of anti-CCR5 monoclonal antibodies, fusion inhibitors, and CD4-GP120 binding inhibitors
#20 | 2006-12-28L-SIGN polymorphisms and methods involving use of same
#21 | 2006-11-21Compositions and methods for inhibition of HIV-1 infection
#22 | 2006-10-19Methods for inhibiting HIV-1 infection
#23 | 2006-10-17Anti-CCR5 antibody
#24 | 2006-09-07Uses of DC-SIGN and DC-SIGNR for inhibiting hepatitis C virus infection
#25 | 2006-06-13Methods for inhibiting HIV-1 infection
#26 | 2006-05-04Stabilized viral envelope proteins and uses thereof
#27 | 2006-04-04Uses of DC-SIGN and DC-SIGNR for inhibiting hepatitis C virus infection
#28 | 2006-04-04Stabilized viral envelope proteins and uses thereof
#29 | 2006-03-09Particle-bound human immunodeficiency virus envelope glycoproteins and related compositions and methods
#30 | 2006-02-09Method for preventing HIV-1 infection of CD4+ cells
#31 | 2005-12-15CD4-IgG2 formulations
#32 | 2005-09-29PSMA formulations and uses thereof
#33 | 2005-06-30CD4-IgG2 formulations
#34 | 2005-06-21Sulfated CCR5 peptides for HIV-1 infection
391732 ⎘